Enhancing Pharmaceutical Analysis with the Microfluidics M110-P

June 11, 2025

Pharmaceutical research today demands reproducibility and scalability. From early-stage formulation to production-scale manufacturing, the consistency of results is not just ideal, it’s essential. Tools that support these goals directly influence the quality and speed of pharmaceutical development. One essential tool is the Microfluidics M110-P, a compact yet powerful high-shear fluid processor.

ATS Scientific Inc., provides Canadian researchers with access to this leading-edge homogenization technology, along with expert support and application knowledge. Our role extends beyond distribution; we are a strategic partner in bringing pharmaceutical innovation to life through tailored solutions and responsive service.

High-Shear Processing for Advanced Drug Formulation

Pharmaceutical formulations are evolving rapidly. Increasingly, developers are turning to Nano emulsions, liposomes, lipid-based nanoparticles, and other nanostructured delivery systems to enhance therapeutic performance. These systems offer better solubility, stability, and targeted delivery, but only if the formulation can be produced with uniform, reproducible particle sizes.

The M110-P is engineered specifically to achieve consistent sub-micron and nano-sized emulsions and dispersions. Its high-shear processing capability enables researchers to control particle size distribution with high precision, which is critical for drug absorption and release profiles. Through ATS Scientific Inc., Canadian pharmaceutical companies and academic labs have local access to this advanced technology and the guidance needed to apply it effectively.

Why this matters:

• Improves bioavailability and therapeutic efficacy
• Enables uniform dosing and controlled release
• Reduces variability across development and production batches

ATS Scientific’s technical experts help ensure the M110-P is optimized for each user’s formulation challenges, offering training and validation support that meets the stringent standards of regulated pharmaceutical environments.

Efficient Cell Disruption for Biotherapeutics

Beyond particle size reduction, the M110-P excels in biological applications. Cell lysis is a fundamental step in extracting intracellular compounds such as proteins, enzymes, and nucleic acids. These components are essential in the development of biopharmaceuticals, including vaccines, antibody therapies, and recombinant proteins.

With guidance from ATS Scientific Inc., users can implement the M110-P for highly efficient, gentle cell disruption, often in just one or two passes, reducing processing time while maintaining the structural integrity of sensitive biomolecules. ATS also assists with method development and application-specific optimization, especially valuable in biotech and bioprocessing sectors.

Scalable and Compliant Technology

One of the most significant advantages of the M110-P is that it provides scalable results. Unlike many benchtop homogenizers, it uses the same fixed-geometry interaction chamber technology as Microfluidics' larger systems. As a result, formulations developed at the lab scale can be transferred seamlessly to pilot or production systems with minimal revalidation.

Through ATS Scientific’s application support and training services, Canadian customers benefit from a deeper understanding of how to scale from research to production efficiently. This ensures faster timelines to clinical development and manufacturing without sacrificing quality.

In addition to scalability, the M110-P is also built for regulatory compliance. It supports cGMP standards with design features that ensure hygienic operation, easy cleaning, and material traceability—critical for any pharmaceutical environment subject to quality audits and inspections.

Key benefits for regulated labs:

• cGMP-compliant construction
• Repeatable, validated processing
• Easy scale-up to production environments

ATS Scientific helps clients meet these regulatory needs by offering documentation support, IQ/OQ validation, and maintenance programs aligned with health authority requirements.

Seamless Integration in Canadian Labs: ATS Scientific Inc.

Canadian life science and pharmaceutical companies turn to ATS Scientific Inc. for more than just access to instruments like the M110-P, they rely on a full-service partner. ATS offers installation and ongoing service to ensure that each system performs at its best. Our long-standing reputation in the Canadian market is built on trusted expertise and responsive customer support.

Whether you’re in a university research facility, a contract development organization (CDMO), or a commercial pharma lab, ATS Scientific ensures the M110-P integrates seamlessly into your workflow. Our team is uniquely positioned to understand local compliance expectations and lab infrastructure needs, making implementation smooth and stress-free.

Driving Innovation in Pharma with ATS Scientific

In an industry where small differences in formulation can have massive implications for safety and efficacy, the Microfluidics M110-P empowers researchers to work with the precision and control required for success. It’s not only a tool for innovation, it’s a bridge between R&D and commercial production.